BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21156663)

  • 21. Add-on therapies to metformin for type 2 diabetes.
    Shomali M
    Expert Opin Pharmacother; 2011 Jan; 12(1):47-62. PubMed ID: 21142694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saxagliptin. No more effective than other gliptins, but a high potential for drug interactions.
    Prescrire Int; 2011 Feb; 20(113):33-7. PubMed ID: 21488586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.
    Kannan S; Pantalone KM; Matsuda S; Wells BJ; Karafa M; Zimmerman RS
    J Diabetes; 2016 Mar; 8(2):279-85. PubMed ID: 25929426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug treatment of type 2 diabetes].
    Tielmans A; Laloi-Michelin M; Coupaye M; Virally M; Meas T; Guillausseau PJ
    Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological management of type 2 diabetes mellitus: an update.
    El-Kaissi S; Sherbeeni S
    Curr Diabetes Rev; 2011 Nov; 7(6):392-405. PubMed ID: 21846326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin-based therapy compared with non-insulin alternatives in elderly patients with type 2 diabetes.
    Zhao Q; Marcy TR
    Consult Pharm; 2013 Aug; 28(8):515-8. PubMed ID: 23906896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metformin role in the treatment of type 2 diabetes in 2008].
    Spada A; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
    Chaudhuri A; Dandona P
    Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Pediatric Type 2 Diabetes.
    Smith JD; Mills E; Carlisle SE
    Ann Pharmacother; 2016 Sep; 50(9):768-77. PubMed ID: 27307414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving therapeutic options for type 2 diabetes mellitus: an overview.
    Guthrie RM
    Postgrad Med; 2012 Nov; 124(6):82-9. PubMed ID: 23322141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials.
    Monami M; Cremasco F; Lamanna C; Marchionni N; Mannucci E
    Diabetes Metab Res Rev; 2011 May; 27(4):362-72. PubMed ID: 21309062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
    Choby B
    FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Hermansen K; Mortensen LS
    Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.
    Fang V; Wazny LD; Raymond CB
    CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacology of antidiabetic drugs: What can be expected of their use?
    Scheen AJ
    Presse Med; 2023 Mar; 52(1):104158. PubMed ID: 36565754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can genetics improve precision of therapy in diabetes?
    Groop L; Storm P; Rosengren A
    Trends Endocrinol Metab; 2014 Sep; 25(9):440-3. PubMed ID: 25028244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.